RootData Free Push Service: Submit exclusive financing info and upon approval, enjoy free App push notifications. [Contact Now]
API Download the RootData App

MEI Pharma Stock Surges on $100 Million Private Placement, Litecoin Treasury Strategy

Dow Jones Newswires

Jul 18, 2025 22:33:00

Share to

By Dean Seal

Shares of MEI Pharma hit a 52-week high after the company said a $100 million private placement will be used to adopt the cryptocurrency Litecoin as its treasury reserved asset.

The stock was up 52% at $6.84 in early trading on Friday. Shares have more than doubled in the past 52 weeks.

The pharmaceutical company said it has entered into securities purchase agreements for a private investment in public equity for the sale of 29.2 million shares at a price of $3.42 each.

In connection with the agreement, MEI has named Litecoin founder Charlie Lee, a lead investor in the stock sale, to its board. It has also made GSR, a digital asset market maker and also lead investor, its digital asset and treasury management advisor.

GSR will oversee the implementation of MEI's Litecoin Treasury Strategy, in which it will stockpile the digital asset as its primary treasury reserve asset.

Write to Dean at dean.seal@wsj.com

Latest News

Upexi Shares Drop After $16.7 Million Cryptocurrency Purchase

Dow Jones Newswires

Jul 24, 2025 01:02:00

CARV (CARV) - CARV x River Staking - 23 Aug 2025

CoinMarketCal

Jul 24, 2025 01:00:21

Elympics (ELP) - KuCoin Listing - 24 Jul 2025

CoinMarketCal

Jul 24, 2025 01:00:21

Upexi Shares Drop After $16.7M Cryptocurrency Purchase

Dow Jones Newswires

Jul 24, 2025 00:47:00

Recent Fundraising

More
$20 M Jul 23
$15.8 M Jul 23
$11.6 M Jul 23

New Tokens

More
Jul 23
Yala YALA
Jul 22
Jul 21

Latest Updates on š•

More